Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Apotex conducting early studies on oral chelating agents

Oct. 27, 1998

Animal studies provide further support for the role of dopaminergic systems in alcoholism

Oct. 26, 1998

Novel orally active iron chelator presented by Novartis researchers

Oct. 21, 1998

Nicotinic acetylcholine receptor ligands from Pfizer for addictive and CNS disorders

Oct. 13, 1998

SmithKline Beecham to market smoking cessation patch in China

Oct. 6, 1998

SmithKline Beecham acquires transdermal nicotine product in Australia and New Zealand

Oct. 5, 1998

Caroverine shown to effective treatment for alcohol withdrawal syndrome

Sep. 22, 1998

Nicotine Inhaler launched nationwide in the U.S.

Sep. 11, 1998

Tropane analogues claimed for cocaine addiction by HHS

Sep. 9, 1998

Spotlight on treatment of substance abuse disorders

Sep. 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...